Chronic photoperiod disruption does not increase vulnerability to focal cerebral ischemia in young normotensive rats by Noor, Ku Mastura Ku Mohd et al.
Original Article
Chronic photoperiod disruption does not
increase vulnerability to focal cerebral
ischemia in young normotensive rats
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Abstract
Photoperiod disruption, which occurs during shift work, is associated with changes in metabolism or physiology (e.g.
hypertension and hyperglycaemia) that have the potential to adversely affect stroke outcome. We sought to investigate if
photoperiod disruption affects vulnerability to stroke by determining the impact of photoperiod disruption on infarct size
following permanent middle cerebral artery occlusion. Adult male Wistar rats (210–290 g) were housed singly under two
different light/dark cycle conditions (n¼ 12 each). Controls were maintained on a standard 12:12 light/dark cycle for nine
weeks. For rats exposed to photoperiod disruption, every three days for nine weeks, the lights were switched on 6 h
earlier than in the previous photoperiod. T2-weighted magnetic resonance imaging was performed at 48 h after middle
cerebral artery occlusion. Disruption of photoperiod in young healthy rats for nine weeks did not alter key physiological
variables that can impact on ischaemic damage, e.g. blood pressure and blood glucose immediately prior to middle
cerebral artery occlusion. There was no effect of photoperiod disruption on infarct size after middle cerebral artery
occlusion. We conclude that any potentially adverse effect of photoperiod disruption on stroke outcome may require
additional factors such as high fat/high sugar diet or pre-existing co-morbidities.
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Introduction
Epidemiological studies have identiﬁed obesity, hyperten-
sion, diabetes, atherosclerosis and inﬂammation as signiﬁ-
cant risk factors for stroke onset and poor outcome.1,2
The incidence and overall disease burden of stroke is pre-
dicted to rise, as these risk factors extend across the
developing world.3,4 In 2007, more than half the global
population lived in a city and this is predicted to reach
70% by 2050. Risk factors for stroke are strongly asso-
ciated with urbanisation mediated through a complex
interaction of lifestyle factors including high-energy
diets, pollution, sedentary lifestyles and disrupted circa-
dian rhythmicity.5
Circadian rhythms are recurring cycles in behavioural
and physiological parameters that are endogenously
driven over a period of approximately 24h and are gen-
erated by feedback loops in the expression of clock genes
that are present in virtually all mammalian cells and by
non-transcription-dependent mechanisms.6,7 Circadian
rhythms persist in the absence of external stimuli,
but under normal living conditions, they are entrained
to external cues such as light, food and physical activity.8
In mammals, overall synchronisation of the circadian
system is governed by a master clock, the suprachias-
matic nuclei (SCN), located within the hypothalamus.9
Light is thought to be the principal time-giving cue (zeit-
geber) transduced by a monosynaptic tract that directly
links light sensitive retinal ganglion cells to the SCN.
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Neuronal activities in the SCN modulate entrainment
through multiple neuro-hormonal pathways to other
brain structures and peripheral oscillators in the other
organs including heart and liver.10 Through these mech-
anisms, entrainment optimises health by ensuring that
the internal rhythms of metabolism and cardiovascular
physiology are synchronised to daily variations in the
light/dark cycle and other recurrent environmental chal-
lenges.11 Erratic cycles in the light/dark cycle, food avail-
ability or social interaction can aﬀect the alignment
between endogenous clocks and the environment, a con-
dition associated with detrimental eﬀects on metabolic
and mental health. Around 20% of workers in the devel-
oped world are required to undertake shift work which
involves chronic disruption of circadian rhythms and
shift work is strongly associated with metabolic dysfunc-
tion and increased risk of cardio and cerebrovascular
diseases.12
Animal studies suggest potential links between dis-
rupted rhythmicity and ischaemic stroke. The spontan-
eously hypertensive rat showed a disrupted circadian
phenotype with impaired capacity to maintain robust
rhythms13 while a progressive desynchronisation of
rhythms in behaviour and drinking was reported to be
a prodromal sign of impending stroke in these animals.14
In healthy individuals, blood pressure (BP) and vascular
contractility show strong daily rhythmicity which indi-
cates underlying clock control, and disruption of these
rhythms is an early sign of cardiovascular diseases in
humans15 and animals.16 Disruption of clock function
by exposure of animals to disrupted photoperiods is
used as a model of circadian disruption, and negatively
aﬀects vascular rhythmicity, function and vulnerability
to ischaemia in organs other than the brain. For exam-
ple, photoperiod disruption (PD) decreased survival in a
hamster model of cardiomyopathy17 and a mouse model
of myocardial infarction18 and compromised vascular
adaptive responses to aortic constriction in mice.19
Furthermore, mice with genetic clock lesions had
impaired pathological remodelling in response to liga-
tion of the carotid artery, enhanced vascular injury
and impaired endothelial function20 and importantly,
increased cell death in the hippocampus following tran-
sient forebrain ischaemia.21 Together with the increased
vulnerability of clock disrupted animals to cardiovascu-
lar ischaemic injury, this suggests that PD might have an
adverse impact on cerebral ischaemic damage.
Some of the reported metabolic or physiological
changes associated with PD such as hypertension and
diabetes have the potential to adversely impact on
stroke. The adverse eﬀect of hyperglycaemia on out-
come after stroke or infarct size after middle cerebral
artery occlusion (MCAO) in rodents is well docu-
mented22,23 while co-morbidities such as genetically
determined hypertension, diabetes or insulin resistance
hasten the demise of the penumbra and increase infarct
volume.24,25 We therefore hypothesise that PD will alter
key physiological variables, such as BP and blood glu-
cose, and increase vulnerability to focal cerebral ischae-
mia. The primary objective of the present study was to
determine if rats subjected to recurrent phase advance of
the light/dark cycle for nine weeks had larger infarcts
compared to animals maintained on a normal light/
dark cycle following permanent MCAO.
Materials and methods
Animals and study design
Experiments were carried out under license from the
UK Home Oﬃce and were subject to the Animals
(Scientiﬁc Procedures) Act, 1986. The report was car-
ried out in accordance with the ARRIVE guidelines
(http://www.nc3rs.org.uk/arrive). Animals were not
randomised to groups but were allocated to control
and PD groups in equal numbers when batches of
four rats were entered into the nine-week protocol
described below. A total of 24 male, adult Wistar rats
(8–10 weeks) weighing 210–290 g were entered into the
study. Rats were singly housed under a standard 12:12
light/dark cycle (lights on at 07:00, lights oﬀ at 19:00)
for two weeks prior to allocation into one of two experi-
mental groups: control (n¼ 12) and PD (n¼ 12). Group
sizes were based on a previous study using the same
method of inducing permanent MCAO that detected
an increase in infarct volume.26
PD protocol
Control rats were housed singly in a room with a stand-
ard 12:12 light/dark cycle for nine weeks. Light intensity
wasmeasured by a luxmeter at the beginning of the study
for the roomhousing the control rats (150 lux). PD rats
were housed singly in a well-ventilated light-tight box
that accommodated two cages per shelf and was con-
nected to a controlled timer. Lights in the box were
switched on 6 h earlier than in the previous photoperiod
every three days for nineweeks as described previously in
a study simulating shift work which demonstrated per-
turbation of circadian biomarkers and changes in blood
glucose and insulin in diabetic-prone rats.27 Light
intensity in the box was maintained at 150 lux similar
to that experienced by the control animals. All rats had
ad libitum access to water and standard rat chow.
Activity monitoring
Activity monitoring was conducted only in the PD rats.
Baseline locomotor activity was recorded two weeks
prior to the commencement of nine weeks phase
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advance protocol, in which the rats were maintained
under standard 12:12 light/dark cycle and for the sub-
sequent nine-week period of PD. Activity was measured
in each individual cage using a passive infra-red sensor
connected to a relay and then to a PC via a 56-channel
interface (ClockLab CL200) that counted events on the
relays in 1min bins. The sensors were positioned above
the cage at a distance that was optimised for detection
of movement in all quadrants and for insensitivity to
movements outside the cage. Data were acquired using
ClockLab software (Actimetrics) and were expressed in
units of beam breaks per min. Disruption of circadian
rhythmicity in locomotor activity was quantiﬁed using
parameters described for assessment of fragmentation
of human rhythmicity.28
Body weight and food intake
In all rats, body weight (BW) and food intake (FI) were
measured at baseline (week 0) and thereafter on a weekly
basis for nine weeks. Food intake was calculated by
weighing the amount of food given each week and cal-
culating the diﬀerence from the previous week.
Tail cuff plethysmography
In all rats, systolic BP was recorded by tail cuﬀ plethys-
mography at baseline and at the end of nine-week
protocol. All animals had been previously conditioned
to the indirect BP set up prior to the study. BP was
measured by the same experimenter at approximately
the same time of the day at every occasion. To facilitate
vasodilatation, animals were placed in an insulated heat
box at 35C–36C for 10min. Five successive BP read-
ings at each session were recorded and the average cal-
culated. The change in BP between baseline and the day
of MCAO was calculated for each rat.
Middle cerebral artery occlusion
At the end of nine weeks, all rats in control and PD
groups were subjected to permanent MCAO by the
same experimenter who was blinded to the animal iden-
tity. Anaesthesia was induced (5% isoﬂurane) and main-
tained by artiﬁcial ventilation with 2% to 3% isoﬂurane
in nitrous oxide–oxygen (70:30). A digital blood glucose
meter (Accu-Check Aviva, Roche, Germany) was used
to measure blood glucose sampled from the tail vein
immediately following induction of anaesthesia. Body
temperature was monitored by a rectal probe and main-
tained at 37C 0.5C using a heat lamp throughout
surgery. Permanent focal cerebral ischemia was induced
by distal occlusion of the middle cerebral artery (MCA)
using the diathermy method adapted from Tamura
et al.29 The MCA was exposed via a craniectomy and
the point at which the MCA crosses the inferior cerebral
vein (ICV) was identiﬁed. The entire portion of MCA
(2mm) above and below the ICV was electrocoagu-
lated with diathermy forceps. Complete MCAO was
conﬁrmed by cutting the electrocoagulated vessel with
microscissors. After recovery from anaesthesia, animals
were returned to their home cage and kept in the recov-
ery area where their general well-being and body weight
were closely monitored three times daily. Animals
received soft diet and ﬂuid, in order to aid recovery.
Magnetic resonance imaging
At 48 h after MCAO, rats were re-anaesthetized and
placed in Bruker Pharmascan 7T magnetic resonance
imaging (MRI) scanner. Rats were maintained under
anaesthesia with 2% to 3% isoﬂurane in nitrous
oxide–oxygen (70:30) using a face mask throughout
the scanning process. Rats were placed into a rat
cradle, the head secured and a phased array surface
coil was positioned above the head. Body temperature
was maintained at 37C 0.5C during scanning using
a temperature-controlled water jacket.
A RARE T2-weighted sequence was acquired
(TE¼ 72ms, TR¼ 5086ms, matrix¼ 256 256, 16 cor-
onal section slices; 0.75mm thick) to image the infarct.
Infarct volume measurement
Infarct volume analysis was performed using Image J
software (NIH, Bethesda, MD), and the assessor was
blinded to the experimental group. Infarct area was
calculated by manually delineating the hyper-intense
regions on T2-weighted images. Infarct volume was cal-
culated by summing the infarct area on each slice and
multiplying by slice thickness (0.75mm). Correction for
oedema was performed to account for brain swelling at
48 h after stroke using previously described method.30
Plasma fructosamine
The bonding of glucose to plasma proteins produces
fructosamine and plasma fructosamine levels are pro-
portional to the average glucose concentration over the
previous two to three weeks prior to the measurement.
Blood for measurement of plasma fructosamine was
collected at 48 h after MCAO. Whole blood was with-
drawn from the heart (via cardiac puncture) and col-
lected into EDTA-treated tubes (1.5ml). Samples were
processed immediately by centrifugation for 10min at
1000 g using a refrigerated centrifuge. Samples were
stored at 80C and analysed at the end of the study.
The fructosamine assay uses the rate of formation of
formazan from nitrotetrazolium blue in an alkaline
environment at 546 nm.31 Reagents were provided by
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Horiba ABX and the analysis was performed on the
Olympus AU 640 chemistry analyser.
Statistical analysis
Data are expressed as scatterplots or mean standard
deviation (SD). All statistical analyses were performed
using GraphPad Prism software v6 (GraphPad, La
Jolla, CA). Changes in BP over time and between
groups were assessed by a two-way analysis of variance.
An unpaired Student’s t test was used to compare ﬁnal
infarct volume, % increase in body weight, blood glucose
and fructosamine level between the groups. A probability
value of 0.05 or less was considered statistically signiﬁcant.
Results
All animals entered into the study completed the entire
experimental protocol; there was no mortality follow-
ing MCAO in either PD or control groups.
Activity monitoring
Rats showed a strong circadian rhythm in locomotor
activity in the baseline 12:12 light/dark period that was
disrupted on commencement of the phase advance
protocol (Figure 1(a)). Loss of circadian rhythmicity
during the PD period compared to the baseline period
was conﬁrmed by changes in the rhythmicity param-
eters, inter-daily stability (IS) and intra-daily variability
(IV) between these periods.
The inter-daily stability was calculated as the ratio
between the variance of the average 24 h pattern around
the mean and the overall variance and reﬂects the pre-
dictability of the diurnal pattern over sequential days.
The IS was signiﬁcantly decreased in the PD period
compared to baseline; 0.76 0.08 and 0.06 0.04 (arbi-
trary units), mean SD for baseline and PD periods,
respectively.
The intra-daily variability index was measured as an
indicator of the fragmentation of the rhythm, with high
values indicative of multiple transitions between
Figure 1. Actogram from a single animal showing disrupted rhythmicity in locomotor activity during chronic photoperiodic phase
advance (a). Rolling seven-day average (mean SD) of the circadian rhythmicity parameters, inter-daily stability (IS) and intra-daily
variability for all animals (IV) (b). The IS decreased from baseline after the PD intervention, indicating disrupted stability of rhythmicity
between days. The IV increase from baseline following the PD, which indicates increased fragmentation of the daily circadian rhythm in
locomotor activity. Mean rhythmicity indices (IS and IV) calculated over the duration of the baseline and PD periods for all animals,
indicated significant changes in both parameters (c) (p< 0.0001, Student unpaired t test).
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periods of rest and activity. Variability within days was
increased by PD as indicated by signiﬁcant increases in
the IV compared to the baseline period (0.75 0.16 and
1.18 0.09 (arbitrary units), mean SD for baseline
and PD periods, respectively (Figure 1(c)). The mean
eﬀect of PD on the rhythmicity of all animals is illu-
strated in Figure 1(b) which shows that both IS and
IV deviated from baseline values when PD commenced,
and that baseline values were not recovered. Therefore,
locomotor activity rhythmicity remained profoundly dis-
rupted for the duration of the PD intervention.
Food intake and body weight
Control and PD groups consumed 21 0.26 and 19.5
0.93 g/day, respectively (daily food intake was calcu-
lated by averaging the weekly intake). As a summative
measure for food intake from baseline to week 9, an area
under the curve was calculated for each rat. This was
1331 96.43 and 1227 100.48g for control and PD,
respectively (Figure 2(a)). The two groups were matched
for body weight at baseline and in both groups, it
increased steadily over time. The mean % increase in
body weight at nine weeks compared to baseline was simi-
lar in control and PD groups. Therefore, PD did not sig-
niﬁcantly alter food intake or body weight (Figure 2(b)).
Blood pressure
The baseline systolic BP for control and PD groups was
98.8 9.5 and 106.4 13.2mmHg, respectively. At
nine weeks, no signiﬁcant diﬀerence in BP was observed
when compared to baseline measurements in either
group (control: 98.7 13.5mmHg and PD: 104.125
11.2mmHg). There was no diﬀerence between control
and PD groups in the degree of change in BP over
nine-week period (Figure 3). Therefore, PD did not sig-
niﬁcantly alter BP.
Blood glucose and plasma fructosamine
Blood glucosewas sampled immediately following induc-
tion of isoﬂurane anaesthesia prior to MCAO. Despite a
slightly higher mean blood glucose level in the PD group
in comparison to the control group, thediﬀerencewas not
statistically signiﬁcant, p¼ 0.056 (Figure 4(a)). Plasma
fructosamine (a measure of glycated protein level) at
48 h after MCAO was not signiﬁcantly diﬀerent between
control and PD rats (188.9 13.6 and 184.5 15.9mmol/
L, respectively, p¼ 0.47 (Figure 4(b)).
Infarct volume
Infarct volume was assessed by T2-weighted MRI 48 h
following MCAO. Infarct volume was not signiﬁcantly
Figure 2. Weekly food intake (a) and % increase in body weight
from baseline (b) in rats kept under 12:12 LD cycle (Control) and
6 h phase advance (PD). Data are presented as mean SD
(p> 0.05, Student unpaired t test).
PD: photoperiod disruption.
Figure 3. BP was comparable for both control and PD group at
baseline. However, PD was not associated with significant %
change in BP for both groups at nine weeks. Data points indicate
individual rats and the horizontal bar represents the mean
(p> 0.05, two-way ANOVA).
PD: photoperiod disruption.
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diﬀerent between control and PD rats (Figure 5(a)
and (b)).
Discussion
Based on associations made between shift work and
metabolic dysfunction in humans,12 we hypothesised
that a chronic period of PD would have an adverse
eﬀect on infarct size after permanent MCAO in rats.
However, our data clearly demonstrate that while rats
exhibited chronic disruption of locomotor activity
rhythms over the nine-week period of PD, infarct size
was not diﬀerent compared to animals maintained on a
normal 12:12 light/dark cycle. Consistent with the lack
of eﬀect of PD on infarct size were the lack of changes
on parameters which inﬂuence stroke outcome: body
weight, BP and blood glucose. The metabolic eﬀects
of PD in experimental studies in animals are notably
inconsistent; this study and others27,32 did not observe
changes in metabolic function reported previously.33
Diﬀerences in the protocols used to induce PD could
partly account for the heterogeneity of the study
results; it is likely that phase advance/delay, constant
light and photoperiod less than 24 h aﬀect both circa-
dian rhythms and metabolism in diﬀerent ways and it
is not clear which intervention most closely represents
disrupted rhythmicity in humans. Furthermore, the
impact of PD on cardio-metabolic function might fur-
ther depend on the wavelength and intensity of light
exposure34 that are not easily compared between
studies. Environmental entrainment is a complex par-
ameter and diﬀerences in the degree of secondary dis-
ruption of food and social rhythmicity might further
contribute to these discrepancies between studies.
Indeed, PD is just one component of the multiple con-
ﬂicting social-, stress- and food-related disruptions to
the lifestyle of the shift worker.
In addition to light-entrainment through the SCN,
emerging evidence supports a strong impact of food
intake on the control of peripheral rhythms.35,36 In noc-
turnal animals, restricting the time for food intake to the
rest phase changed clock gene expression in liver and
pancreas but not in the SCN37 and caused increased
body weight.35 In this case, weight gain is due to uncou-
pling between peripheral clocks and light signal from the
central pacemaker.38 In the present study, the animals
had free access to food at all times of day and it is pos-
sible that they maintained synchronisation of food
intake to the disrupted light/dark cycles and that enabled
them to accommodate the challenge of PD without com-
prised metabolic function. Animals subjected to PD in
the laboratory may maintain overall synchronisation if
food rhythms remain intact, and further studies that
measure temporal aspects of food mediated cues are
required to resolve this issue. The rhythmicity of the
shift worker is diﬀerent to that of their family and
friends, while in rats, all of the animals share the same
(disrupted) photoperiod. This important diﬀerence
between circadian disruption in the laboratory, and in
real life might account for the inconsistent reports of the
impact of PD on metabolic health. The ﬁndings that
animals in some laboratories were able to maintain
metabolic health despite PD indicate that unidentiﬁed
factors may protect animals from the detrimental eﬀects
of light disruption. Future studies should focus on iden-
tifying if entrainment to social or food-related zeitgebers
can help animals to accommodate PD, and if similar
interventions can attenuate the risks of shift work for
metabolic and vascular health in humans.
Young, normotensive Wistar rats were used in the pre-
sent study and chronic PD had no impact on BP which is
concordant with similar ﬁndings in normotensive Wistar
rats subjected to 12 weeks of PD.39 Gale et al.27 suggest
Figure 4. Blood glucose levels immediately prior to MCAO (a).
Data points indicate individual rat and the horizontal bar repre-
sents the mean. Plasma fructosamine level at 48 h after MCAO
(b) reflects average glycaemic levels two to three weeks prior to
MCAO (p> 0.05, Student unpaired t test).
PD: photoperiod disruption.
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that the interaction of genetic predisposition with an
environmental trigger (such as PD) further accelerates
early development of hyperglycaemia in diabetic prone
rats compared to wild type. Other studies demonstrate
that 12 h phase shift in the light/dark cycle on a weekly
basis causes a signiﬁcant reduction in survival time
in cardiomyopathic hamsters17 and a higher mortality
rate in aged mice.40 Thus, the adverse eﬀects of PD on
health may be manifested in the context of existing fac-
tors such as advanced age, hypertension, insulin resist-
ance or genetic variation. Our results demonstrate that
PD alone was not suﬃcient to increase vulnerability to
stroke in young rats without stroke co-morbidities.
One potential caveat of the present study is that it
was not suﬃciently powered to detect an eﬀect of PD
on infarct volume. When designing the study, the ori-
ginal sample size was calculated based on previous data
from our laboratory using the same model of MCAO
and strain of rat which detected a 50% increase in
infarct volume associated with hyperglycaemia.26
Using the data obtained from the control group in
the current study, a group size of 14 is predicted neces-
sary to detect a 50% increase in infarct volume and so it
does not appear likely that an eﬀect of PD was missed
due to a Type II error. The present study was suﬃ-
ciently powered to be able to detect at least a 50%
change in infarct volume. We conclude that young
healthy individuals may be resilient to any impact
that PD, as a consequence of shift work or other envir-
onmental inﬂuences, may have on sensitivity to stroke.
However, the potential adverse impact of PD on stroke
outcome in the context of concomitant disruption of
food or social zeitgebers or additional pathological
challenges from a sedentary lifestyle, a high fat/high
sugar diet, ageing or pre-existing co-morbidities war-
rant future investigation.
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